Varex Imaging Corp
VREXNasdaqTechnology · Electronic Components, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $844.6M | $811.0M | $893.4M | $859.4M | $818.1M | $738.3M |
| Operating income | −$27.8M | $32.1M | $77.1M | $88.2M | $74.1M | −$33.7M |
| Net income | −$70.3M | −$48.8M | $47.4M | $30.3M | $17.4M | −$57.9M |
| Total assets | $1.11B | $1.21B | $1.25B | $1.18B | $1.15B | $1.14B |
| Total liabilities | $620.8M | $670.4M | $668.6M | $637.7M | $651.0M | $673.7M |
| Equity | $472.6M | $529.1M | $567.7M | $533.4M | $483.3M | $451.7M |
| EPS (diluted) | $-1.70 | $-1.20 | $1.07 | $0.73 | $0.43 | $-1.49 |
| Shares out. | 41.7M | 41.1M | 40.5M | 40.1M | 39.5M | 39.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3.3%
- Net margin
- −8.3%
- Return on equity
- −14.9%
- Return on assets
- −6.3%
- Return on capital (ROCE)
- −3.0%
- Liabilities / assets
- 56.1%
- Debt / equity
- 1.31×
- Book value / share
- $11.33
- Revenue growth (YoY)
- 4.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 3.31safe
- Accruals / assets
- −10.1%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 13, 2020
- NT 10-Qmissed a reporting deadline ↗Feb 12, 2020
- NT 10-Kmissed a reporting deadline ↗Nov 27, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 27, 2026
- Dimensional Fund Advisors LpPassive (13G)Oct 9, 2025
- Pzena Investment Management LlcPassive (13G)Jul 3, 2025
- Blackrock, Inc.Passive (13G)Apr 17, 2025
- Cooke & Bieler LpPassive (13G)Feb 12, 2025
- Shapiro Capital Management LlcPassive (13G)Nov 14, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.3M | 2.0 | -19.1% |
| Apr 30, 2026 | 1.6M | 5.6 | +15.8% |
| Apr 15, 2026 | 1.4M | 6.4 | +1.1% |
| Mar 31, 2026 | 1.4M | 5.1 | +2.8% |
| Mar 13, 2026 | 1.3M | 4.1 | +12.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 7, 2026
- Entered a material agreement · Terminated a material agreement · New financial obligation · Other material eventMar 16, 2026
- Shareholder voteFeb 13, 2026
- Results of operationsFeb 10, 2026
- Results of operationsNov 18, 2025
- Director / officer changeSep 11, 2025
- Results of operationsAug 7, 2025
- Results of operationsMay 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spun off from Varian Medical Systems · Jan 27, 2017
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.